15-OXA-steroid compounds

Details 15-OXA-steroid compounds 15-OXA-steroid compounds

2011-05-24

2011-05-24

Badio, Barbara P (Department: 1628)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S468000

Reexamination Certificate

active

07947846

ABSTRACT:
The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the invention include methyl-2,3,4-trihydroxy-1-O-(7,17-dioxoandrost-5 -ene-3β-yl)-β-D-glucopyranosiduronate, 16α,3α-dihydroxy-5α-androstan-17-one or 3,7,16,17 -tetrahydroxyandrost-5-ene, 3,7,16,17-tetrahydroxyandrost-4-ene, 3,7,16,17 -tetrahydroxyandrost-1-ene or 3,7,16,17-tetrahydroxyandrostane that can be used in the treatment method.

REFERENCES:
patent: 3987066 (1976-10-01), Rosen
patent: 4066666 (1978-01-01), Rosen
patent: 5219879 (1993-06-01), Ko et al.
patent: 7696189 (2010-04-01), Frincke
patent: 7723532 (2010-05-01), Frincke et al.
patent: 7863261 (2011-01-01), Frincke
patent: 782736 (2005-08-01), None
patent: 2388939 (2009-06-01), None
patent: 1223941 (2008-05-01), None
patent: WO 01/30802 (2001-05-01), None
patent: WO 01/30802 (2001-05-01), None

Affiliated with

Also associated with

Rating

15-OXA-steroid compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 15-OXA-steroid compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 15-OXA-steroid compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2700415